Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Baylor College of Medicine
H. Lee Moffitt Cancer Center and Research Institute
Baylor College of Medicine
Immatics US, Inc.
Acepodia Biotech, Inc.
HRYZ Biotech Co.
Fate Therapeutics
Fate Therapeutics
Fate Therapeutics
Genocea Biosciences, Inc.
Corregene Biotechnology Co., Ltd
Mie University
Emory University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mie University
Herlev Hospital